CompletedNot Applicable

Cardiac Resynchronization Therapy in Congenital Heart Diseases With Systemic Right Ventricle

85 participantsStarted 2004-01-01

Plain-language summary

This study aims to analyze outcomes of patients with systemic right ventricle (SRV) implanted with Cardiac Resynchronization Therapy (CRT) systems and to compare the impact of CRT in SRV patients with other congenital heart diseases (CHD).

Who can participate

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * All patients with congenital heart disease and CRT device Exclusion Criteria: * Patient's refusal

What they're measuring

Proportion of patients with response to CRT

Timeframe: 6-month, 12-month, 24-month

Proportion of patients with response to CRT

Timeframe: 12-month

Proportion of patients with response to CRT

Timeframe: 24-month

Trial details

NCT IDNCT04842851

SponsorParis Cardiovascular Research Center (Inserm U970)

Sponsor typeOTHER_GOV

Study typeOBSERVATIONAL

Primary completion2020-12-31

View on ClinicalTrials.gov More Congenital Heart Disease trials